A new report by MarketsandMarkets projects that the global veterinary software market will grow at a compound annual growth rate (CAGR) of 6.1% from 2017 to 2022. The growth drivers include rising companion animal ownership and demand for pet insurance.
The global cell counting market is experiencing healthy growth, according to a recent industry report from marketsandmarkets. Valued at $10.4 billion in 2020, the market is forecasted to reach $14.5 billion by 2025, representing a 6.7% compound annual growth rate.
A new report from MarketsandMarkets projects strong growth in the global healthcare asset management market over the next several years.
The global cell expansion market was valued at $14.9 billion in 2020 and is projected to reach $30.1 billion by 2025, growing at a compound annual growth rate (CAGR) of 15.1% during that period, according to a new report from MarketsandMarkets Research.
The global dental digital x-ray market is experiencing rapid expansion, poised to grow from $4.0 billion in 2022 to $7.0 billion by 2027 at an impressive 11.9% compound annual growth rate (CAGR), according to the latest report by MarketsandMarketsTM.
The global blood culture tests market is projected to grow at a compound annual growth rate (CAGR) of 8% from 2023 to 2028 to reach $7.6 billion by 2028, according to a new report from MarketsandMarkets Research.
The global urinalysis market was valued at $3.9 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2022 to 2027 to reach $5.7 billion, according to a new report from MarketsandMarkets.
The global microbial identification market is projected to grow at a compound annual growth rate (CAGR) of 12.2% from 2020 to 2025 to reach $5.7 billion by 2025, according to a new report from MarketsandMarkets.
The global advanced wound care market is poised for robust growth in the coming years, according to a new report from marketsandmarkets.
The global cell based assays market is expected to see robust growth in the coming years, according to new research from MarketsandMarkets. The market, valued at $18.9 billion in 2023, is projected to reach $28.2 billion by 2028, expanding at a compound annual growth rate (CAGR) of 8.4%.The report cites rising demand for drug discovery and development as a major driver fueling the growth of cell based assays.
